Terns Pharmaceuticals Inc (TERN)
5.44
+0.15
(+2.84%)
USD |
NASDAQ |
May 03, 16:00
5.435
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Cash from Operations (TTM): -67.39M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -67.39M |
| September 30, 2023 | -59.28M |
| June 30, 2023 | -52.02M |
| March 31, 2023 | -50.19M |
| December 31, 2022 | -49.11M |
| September 30, 2022 | -48.57M |
| June 30, 2022 | -43.21M |
| Date | Value |
|---|---|
| March 31, 2022 | -40.81M |
| December 31, 2021 | -41.83M |
| September 30, 2021 | -38.54M |
| June 30, 2021 | -36.78M |
| March 31, 2021 | -36.84M |
| December 31, 2020 | -29.81M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-67.39M
Minimum
Dec 2023
-29.81M
Maximum
Dec 2020
-45.72M
Average
-43.21M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
| Viking Therapeutics Inc | -54.87M |
| Eli Lilly and Co | 3.676B |
| Pfizer Inc | 8.70B |
| Amgen Inc | 8.096B |
| Madrigal Pharmaceuticals Inc | -324.23M |